Dr. Morris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
Mail Code 8208
San Diego, CA 92103Phone+1 619-543-8080
Education & Training
- University of California (San Francisco) School of MedicineFellowship, Sexually Transmitted Disease, 2005 - 2006
- University of California (San Francisco)/University of California School of Public HealthResidency, Public Health and General Preventive Medicine, 2004 - 2005
- Harvard School of Public HealthMPH, Quantitative Methods, 2000 - 2002
- University of British ColumbiaClass of 1990
Certifications & Licensure
- CA State Medical License 2004 - 2026
- American Board of Preventive Medicine Public Health & General Preventive Medicine
Clinical Trials
- A Web-based Intervention Study to Reduce High-risk Sexual Behavior by Persons Living With HIV AIDS (PLWH) Start of enrollment: 2010 Jul 09
- CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM Start of enrollment: 2012 Dec 19
- Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women Start of enrollment: 2016 May 01
- Join now to see all
Publications & Presentations
PubMed
- 38 citationsPerformance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sect...Sheldon R. Morris, Claire C. Bristow, Michael R. Wierzbicki, Mark Sarno, Lenore Asbel
The Lancet. Infectious Diseases. 2021-05-01 - 99 citationsRandomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.Craig R Cohen, Michael R Wierzbicki, Audrey L French, Sheldon Morris, Sara Newmann
The New England Journal of Medicine. 2020-05-14 - 36 citationsLong-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96...Onyema Ogbuagu, Peter Ruane, Daniel Podzamczer, Laura C Salazar, Keith Henry
The Lancet. HIV. 2021-07-01
Journal Articles
- Trajectories and Predictors of Longitudinal Preexposure Prophylaxis Adherence Among Men Who Have Sex with MenJill Blumenthal, David J Moore, Michael P Dube, Sheldon R Morris, The Journal of Infectious Diseases
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: